Oric Pharmaceuticals, Inc.
ORIC • NASDAQ
Oric Pharmaceuticals, Inc. is a biotechnology company in the healthcare sector trading on NASDAQ, led by CEO Jacob Chacko, with a market cap of $970.0M.
CEOJacob Chacko
Market Cap$970.0M
Biotechnology
Healthcare
Employees102.0
Websiteoricpharma.com
Country
United States of America
Next Earnings
Upcoming earnings announcement for Oric Pharmaceuticals, Inc.
Date
Monday, May 4, 2026 (in 3 months)
Timing
After Market Close (4:00 PM New York)
Fiscal Period
Q1 2026
EPS Estimate
-$0.37
Earnings History
Past 11 earnings reports for Oric Pharmaceuticals, Inc.
| Date | Period | EPS | EPS Surprise | Revenue | Rev. Surprise | Filing |
|---|---|---|---|---|---|---|
| Nov 13, 2025 | Q3 2025 | -$0.33Est: -$0.40 | +17.5% | - | — |  10-Q |
| Aug 12, 2025 | Q2 2025 | -$0.47Est: -$0.45 | -4.4% | - | — | 10-Q |
| May 5, 2025 | Q1 2025 | -$0.42Est: -$0.51 | +17.6% | - | — | 10-Q |
| Feb 18, 2025 | Q4 2024 | -$0.51Est: -$0.51 | 0.0% | - | — | 10-K |
| Nov 12, 2024 | Q3 2024 | -$0.49Est: -$0.47 | -4.3% | - | — | 10-Q |
| Aug 12, 2024 | Q2 2024 | -$0.45Est: -$0.41 | -9.8% | - | — | 10-Q |
| May 6, 2024 | Q1 2024 | -$0.37Est: -$0.51 | +27.5% | - | — | 10-Q |
| Mar 11, 2024 | Q4 2023 | -$0.49Est: -$0.49 | 0.0% | - | — | 10-K |
| Nov 6, 2023 | Q3 2023 | -$0.44Est: -$0.46 | +4.3% | - | — | — |
| Aug 10, 2023 | Q2 2023 | -$0.50Est: -$0.57 | +12.3% | - | — | 10-Q |
| May 8, 2023 | Q1 2023 | -$0.53Est: -$0.54 | +1.9% | - | — | 10-Q |